Azo chemistry and its potential for colonic delivery

Area of Science:

• Pharmacology
• Gastroenterology
• Drug Delivery Systems

Background:

• Localized colon diseases necessitate advanced drug delivery systems.
• Current treatments often face challenges with systemic side effects and suboptimal drug concentrations at the target site.
• Colon-specific drug delivery aims to improve therapeutic outcomes by concentrating medication within the colon.

Purpose of the Study:

• To explore the potential of azo-cross-linked polymers for colon-specific drug delivery.
• To investigate strategies for protecting drugs from the upper gastrointestinal tract environment for targeted release in the colon.
• To highlight the advantages of colon-specific delivery, including reduced systemic exposure and improved drug efficacy.

Main Methods:

• Utilizing microbially degradable polymers, specifically azo-cross-linked systems, as carriers for oral drug administration.
• Developing prodrugs, such as sulfasalazine, ipsalazine, balsalazine, and olsalazine, which incorporate azo linkages.
• Leveraging the colonic environment's enzymatic activity (azo-reductase) for targeted drug release.

Main Results:

• Azo-conjugation protects drugs from degradation and absorption in the upper gastrointestinal tract.
• Colonic bacteria and associated enzymes facilitate the cleavage of azo linkages, releasing the active drug in the colon.
• This approach enables site-specific delivery of drugs like 5-amino salicylic acid for inflammatory bowel disease treatment.

Conclusions:

• Azo-cross-linked polymers represent a promising strategy for colon-specific drug delivery.
• This method enhances drug efficacy for localized colon diseases by ensuring targeted release and minimizing systemic side effects.
• Further research into colon-specific delivery systems holds significant potential for treating gastrointestinal disorders.